AMERICAN SOCIETY CLINICAL PHARMACOLOGY

Brand	Owner (click to sort)	Address	Description
AMERICAN SOCIETY FOR CLINICAL PHARMACOLOGY & THERAPEUTICS	American Society for Clinical Pharmacology & Therapeutics	528 N Washington St. Alexandria VA 22314	AMERICAN SOCIETY FOR CLINICAL PHARMACOLOGY AND THERAPEUTICS;Association services, namely, promoting the interests of professionals whose primary interest is to advance the science and practice of clinical pharmacology and translational medicine for the therapeutic benefit of patients and society;SOCIETY;
ASCPT	American Society for Clinical Pharmacology & Therapeutics	528 N Washington St. Alexandria VA 22314	AMERICAN SOCIETY FOR CLINICAL PHARMACOLOGY AND THERAPEUTICS;Association services, namely, promoting the interests of professionals whose primary interest is to advance the science and practice of clinical pharmacology and translational medicine for the therapeutic benefit of patients and society;
	Where the owner name is not linked, that owner no longer owns the brand

Technical Examples

The invention provides isolated polynucleotide molecules, including plasmids; viral vectors; and transfected host cells that comprise a DNA sequence encoding an infectious RNA sequence encoding a North American PRRS virus; and also North American PRRS viruses encoded thereby. The invention further provides isolated infectious RNA molecules encoding a North American PRRS virus. The invention also provides isolated polynucleotide molecules, infectious RNA molecules, viral vectors, and transfected host cells encoding genetically-modified North American PRRS viruses; and genetically-modified North American PRRS viruses encoded thereby. The invention also provides vaccines comprising such plasmids, RNA molecules, viral vectors, and North American PRRS viruses, and methods of using these vaccines in swine and in other animals. Also provided are isolated polynucleotide molecules, viral vectors, and transfected host cells that comprise a nucleotide sequence encoding a peptide of a North American PRRS virus. These viral vectors and transfected host cell lines are useful in providing peptides to compensate for mutated peptide coding sequences of DNA sequences encoding genetically-modified North American PRRS viruses so that functional virions can be generated.